What is CorMedix's operating cash flow?

CorMedix (CRMD) reported operating cash flow of $42.38M in Q1 2026.

How has CorMedix's operating cash flow changed year-over-year?

CorMedix's operating cash flow increased by 114.7% year-over-year, from $19.74M to $42.38M.

What is the long-term trend for CorMedix's operating cash flow?

Over 4 years (2021 to 2025), CorMedix's operating cash flow has grown at a 69.6% compound annual growth rate (CAGR), from -$21.16M to $175.05M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

CorMedix CRMD Operating Cash Flow

Operating Cash Flow at other companies

PfizerPFE

$2.62B+12.0%

Merck & Co.MRK

$3.92B+56.7%

Merit Medical SystemsMMSI

$40.68M+0.3%

ITG

Integer HoldingsITGR

$24.7M-21.0%

IAR

Integra LifeSciencesIART

$9.8M+187%

MiMedx GroupMDXG

$1.88M-64.5%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's operating cash flow?: CorMedix (CRMD) reported operating cash flow of $42.38M in Q1 2026.
How has CorMedix's operating cash flow changed year-over-year?: CorMedix's operating cash flow increased by 114.7% year-over-year, from $19.74M to $42.38M.
What is the long-term trend for CorMedix's operating cash flow?: Over 4 years (2021 to 2025), CorMedix's operating cash flow has grown at a 69.6% compound annual growth rate (CAGR), from -$21.16M to $175.05M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.